The co-pay card debate simmers, as payers push back

Will this payer pressure pose an existential threat to co-pay cards even though patients love them?

Shire taps Jennifer Aniston for awareness campaign as it enters the eye care market

The drugmaker expects the multi-channel initiative to lay its foundation in the ophthalmology market.

Five things for pharma marketers to know: Friday, August 26, 2016

Five things for pharma marketers to know: Friday, August 26, 2016

Sarah Jessica Parker cuts ties with Mylan over pricing controversy; lung-cancer physicians turn to Keytruda; Merck KGaA diversifies its business

Drugmakers revive R&D focus on long stagnant women's health market

Drugmakers revive R&D focus on long stagnant women's health market

Fueled by innovation in new treatments, the underserved women's health market has begun to turn the proverbial corner. What took it so long?

Top 25 women's health products, ranked by 2016 forecasts

Top 25 women's health products, ranked by 2016 forecasts

Amgen's osteoporosis drug Prolia is the category leader, projected to bring in $992 million in sales in 2016.

Five things for pharma marketers to know: Thursday, August 25, 2016

Five things for pharma marketers to know: Thursday, August 25, 2016

Mylan offers additional copay assistance for EpiPen amid criticism; fewer doctors are seeing reps; two Copaxone patents are invalidated

Anti-smoking group Truth releases musical FOMO spot for MTV Video Music Awards

Anti-smoking group Truth releases musical FOMO spot for MTV Video Music Awards

The anti-tobacco movement Truth is hitting young people in their pocketbooks with a new spot called "Squadless."

Five things for pharma marketers to know: Wednesday, August 24, 2016

Five things for pharma marketers to know: Wednesday, August 24, 2016

Retzlaff files a complaint against Turing; Pfizer to buy antibiotics from AstraZeneca; Mylan's marketing for EpiPen faces criticism

Five things for pharma marketers to know: Tuesday, August 23, 2016

Five things for pharma marketers to know: Tuesday, August 23, 2016

Grassley blasts Mylan over EpiPen price increases; Portola Pharmaceuticals receives CRL letter for reversal agent; the FDA approves Pfizer's opioid

In Medivation deal, Pfizer will gain an oncology blockbuster

In Medivation deal, Pfizer will gain an oncology blockbuster

Pfizer's commercial expertise in urology and oncology could help propel Medivation's Xtandi to new heights.

Long neglected, the osteoporosis market prepares for new entrants

Long neglected, the osteoporosis market prepares for new entrants

The osteoporosis drug market is bracing for the advent of potentially game-changing treatments.

Five things for pharma marketers to know: Monday, August 22, 2016

Five things for pharma marketers to know: Monday, August 22, 2016

Pfizer to acquire cancer drugmaker Medivation; Valeant names new CFO; Apple acquires health data startup

Reimbursement rather than Brexit more likely to impact how drugmakers order global launches

Reimbursement rather than Brexit more likely to impact how drugmakers order global launches

The current reimbursement climate is more likely to impact how drugmakers order their global product launches than the U.K.'s vote to exit the E.U.

Five things for pharma marketers to know: Friday, August 19, 2016

Five things for pharma marketers to know: Friday, August 19, 2016

Another study finds doctors who receive gifts from drugmakers prescribe their drugs; Part D spending rose 17% in 2014; Mallinckrodt to open New Jersey site

Expect healthcare agencies to make more digital acquisitions: report

Expect healthcare agencies to make more digital acquisitions: report

Mergers and acquisitions targeting digital and data capabilities increased 60% to $1 billion in the first half of 2016.

Five things for pharma marketers to know: Thursday, August 18, 2016

Five things for pharma marketers to know: Thursday, August 18, 2016

Court clears Pfizer to move ahead with Remicade biosimilar; McDonald's yanks activity trackers over skin irritation; California drug-pricing bill pulled

Bolstered by new data, Radius Health focuses on unmet needs in the osteoporosis market

Bolstered by new data, Radius Health focuses on unmet needs in the osteoporosis market

Only one new osteoporosis drug has been approved over the last six years.

Read the complete August 2016 digital edition

Read the complete August 2016 digital edition

Read about MM&M's inaugural Hall of Femme event and the rest of the MM&M August issue.

Five things for pharma marketers to know: Wednesday, August 17, 2016

Five things for pharma marketers to know: Wednesday, August 17, 2016

AHIP study says half of orphan-drug usage is for non-orphan indications; Studies of GSK weight-loss pill underestimated side effects; ViiV starts HIV trial

Healthline's traffic rises, putting it closer to WebMD and Everyday Health

Healthline's traffic rises, putting it closer to WebMD and Everyday Health

The health site had a 44% increase in unique visitors in July 2016, compared to the same month a year ago.

Agency Spotlight


OPINION

Email Newsletters